The last paragraph of the first section of this article(Metabolic pathway) is missing a word and does not make sense as it stands: "The end product of a pathway may be used immediately, initiate another metabolic pathway or be stored for later use." In addition to this minor grammatical issue, as noted by other users, this article is missing proper citation in some areas. Over all this article could be expanded to discuss more aspects of the full chart for metabolic pathways. ~~~~ Anipamil is a calcium blocker channel, specifically of the phenylalkylamine type. This type is separate from its more common cousin dihydropyridines. Anipamil is an anologo of the more common drug verapamil. Anipamil is more effective as an antiarrhythmic medicatoin than verapamil because it does not cause hypertension Anipamil bonds to the miocardium stronger then verapamil


Source: Dillon JS, Nayler WG. The calcium antagonist and binding properties of the phenylalkylamine, anipamil.Br J Pharmacol 1988;94:253–263. --This shows Anipamil is indeed a Ca blocker